Technology Foundation to Accelerate
and Scale Product Development

  • Alexion Boehringer Ingelheim CSL Emmes GSK Moderna

“Our strategic partnership with Veeva expands our capacity to leverage innovative technology and enhances our ability to deliver value to patients and all our stakeholders – this is key to how we measure success.”

-Robert M Davis, Chief Executive Officer and President, Merck

Read the Press Release

Greater Efficiency and Innovation

GSK
Standardizing Common Data and Processes Across R&D

Sarepta
Time Savings and Data Consistency with Regulatory and Quality Connection

Argenx
Greater Efficiency and Transparency with Veeva Development Cloud

Merck
Building a Veeva Center of Excellence

LEO
Streamlining Product Development with a Unified Platform

Inhibrx
Deploying an R&D System Foundation in 4.5 Months

Idorsia
Why Idorsia Standardized on Clinical, Quality, and Regulatory

Alexion
Alexion Supports Rapid Growth with Veeva Development Cloud

Boehringer Ingelheim
How Boehringer Ingelheim Deepened its Digital Transformation

Lysarc
LYSARC Partners with Veeva to Accelerate Innovation for Lymphoma Treatments

Emmes
Emmes Standardizes on Veeva Development Cloud to Streamline Product Development

Gilead, AbbVie
Best Practices for Bringing Acquired Companies into a Veeva Environment

Streamline Cross-Functional Business Processes with Veeva Connections

Veeva Quality and Veeva RIM Connection

How Moderna is Automating Change Control and Variation Management

UCB Streamlines Change Control and Variation Management

Veeva RIM to Clinical Operations

Cerevel Bridges Gap Between Regulatory and Clinical

UroGen Pharma Streamlines Clinical and Regulatory Operations

Veeva RIM to PromoMats

Pacira Explores Commercial and Regulatory Connection to Streamline Promotional Material Submissions

Veeva Connections Live Discussions: Register here

Interested in learning more about how Veeva can help?

Contact us